TrialTrials2017

A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.

Theodoros Kassimatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.